SCHEMBL1881134

SCHEMBL1881134

CC(=O)C=Cc1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 4/20 1.00
PTGS1 P23219 1/20 1.00
APP P05067 3/20 0.69
TTR P02766 3/20 0.69
KDM4E B2RXH2 2/20 0.69
HSD17B10 Q99714 2/20 0.69
MAPT P10636 2/20 0.69
PTPN1 P18031 2/20 0.69
DPP4 P27487 2/20 0.69
MEN1 O00255 1/20 0.69
HDAC3 O15379 1/20 0.69
CA12 O43570 1/20 0.69
AKR1B10 O60218 1/20 0.69
ALDH1A1 P00352 1/20 0.69
CA1 P00915 1/20 0.69
CA2 P00918 1/20 0.69
LMNA P02545 1/20 0.69
MMP1 P03956 1/20 0.69
GLA P06280 1/20 0.69
POLB P06746 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29364807 1.00 IAPP (1.00) IAPPPTGS1APPTTRKDM4E
SCHEMBL1881133 1.00 IAPP (1.00) IAPPPTGS1APPTTRKDM4E
Hispolon SCHEMBL15917284 0.85 IAPP (0.74) IAPPPTGS1APPTTRKDM4E
Hispolon SCHEMBL15917285 0.85 IAPP (0.74) IAPPPTGS1APPTTRKDM4E
Hispolon SCHEMBL17414113 0.85 IAPP (0.74) IAPPPTGS1APPTTRKDM4E
Hispolon SCHEMBL30875919 0.85 IAPP (0.74) IAPPPTGS1APPTTRKDM4E
SCHEMBL12220501 0.85 IAPP (0.73) IAPPPTGS1APPTTRKDM4E
SCHEMBL21986902 0.85 IAPP (0.73) IAPPPTGS1APPTTRKDM4E
SCHEMBL21986720 0.85 IAPP (0.73) IAPPPTGS1APPTTRKDM4E
SCHEMBL2221673 0.83 KDM4E (0.74) IAPPPTGS1APPTTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107441078-B A kind of pharmaceutical composition and its preparation method and application for treating diabetes 中南民族大学 2018-10-26 CN claimed
CN-107441078-A A kind of pharmaceutical composition for treating diabetes and its production and use 中南民族大学 2017-12-08 CN claimed
JP-4202127-A None JP disclosed
US-20250327100-A1 Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase BGENE GENETICS (FR) 2025-10-23 US disclosed
CN-120284927-A Application of 3, 4-dihydroxybenzylidene acetone in preparation of medicine for relieving intestinal injury of Leizhou black ducks 广东海洋大学 2025-07-11 CN disclosed
CN-120284927-A Application of 3, 4-dihydroxybenzylidene acetone in preparation of medicine for relieving intestinal injury of Leizhou black ducks 广东海洋大学 2025-07-11 CN disclosed
CN-119818462-A Chinese medicinal composition containing Osmunda japonica ketone and application thereof in preparing medicament for preventing and treating diabetic complications 北京中医药大学 2025-04-15 CN disclosed
CN-119818461-A Traditional Chinese medicine composition and application thereof in preparation of medicines for treating diseases related to abnormal proliferation of epithelial cells 北京中医药大学 2025-04-15 CN disclosed
CN-119345166-A Application of Osmunotone in promotion of collagen and/or elastin production 上海家化联合股份有限公司 2025-01-24 CN disclosed
CN-119345165-A Anti-glycation application of osmunda japonica ketone 上海家化联合股份有限公司 2025-01-24 CN disclosed
CN-119345164-A Anti-inflammatory and soothing effects of Osmunotone and application thereof 上海家化联合股份有限公司 2025-01-24 CN disclosed
CN-100346776-C Remedies TAKARA BIO INC (JP) 2007-11-07 CN disclosed
US-7268160-B2 Remedies TAKARA BIO, INC. (JP) 2007-09-11 US disclosed
EP-1666440-A1 METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND Sumitomo Chemical Company, Limited (JP) 2006-06-07 EP disclosed
US-6689767-B2 TRITERPENE BACTERICIDES REGENTS OF THE UNIVERSITY OF MINNESOTA 2004-02-10 US disclosed
US-6689767-B2 TRITERPENE BACTERICIDES REGENTS OF THE UNIVERSITY OF MINNESOTA 2004-02-10 US disclosed
US-20030144316-A1 Remedies TAKARA BIO INC. (JP) 2003-07-31 US disclosed
CN-1419448-A Remedies TAKARA BIO INC (JP) 2003-05-21 CN disclosed
EP-1254658-A1 REMEDIES TAKARA BIO INC. (JP) 2002-11-06 EP disclosed
JP-H04202127-A INTERLEUKIN-1 PRODUCTION-INHIBITING AGENT TERUMO CORP 1992-07-22 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144316-A1 Remedies NGF, BDNF, NTRK2 IAPP 42/4885PTGS1 200/4885APP 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.